M A Winters
Overview
Explore the profile of M A Winters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lloyd Jr R, Burns D, Huong J, Mathis R, Winters M, Tanner M, et al.
J Clin Microbiol
. 2009 Mar;
47(5):1491-6.
PMID: 19321732
A novel method for the collection and transportation of dried-blood-plasma samples, SampleTanker (ST), was developed and compared to standard shipping protocols for frozen-plasma specimens containing human immunodeficiency virus type 1...
2.
Kaufer D, Ogle W, Pincus Z, Clark K, Nicholas A, Dinkel K, et al.
Nat Neurosci
. 2004 Aug;
7(9):947-53.
PMID: 15300253
Glucocorticoids, the adrenal steroids released during stress, compromise the ability of neurons to survive neurological injury. In contrast, estrogen protects neurons against such injuries. We designed three genetic interventions to...
3.
Kim E, Winters M, Kagan R, Merigan T
J Virol
. 2001 Oct;
75(22):11227-33.
PMID: 11602763
Twenty-four of over 24,000 patients genotyped over the past 3 years were found to have human immunodeficiency virus (HIV) isolates that possess an insert in the protease gene. In this...
4.
Shulman N, Machekano R, Shafer R, Winters M, Zolopa A, Liou S, et al.
J Acquir Immune Defic Syndr
. 2001 Jul;
27(4):377-80.
PMID: 11468426
Prior evidence suggests that resistance to zidovudine (ZDV) confers some degree of cross-resistance to stavudine (d4T), but no genotypic correlates of clinical d4T susceptibility and resistance exist. To identify the...
5.
Winters M, Merigan T
Antimicrob Agents Chemother
. 2001 Jul;
45(8):2276-9.
PMID: 11451685
The T69D mutation in the human immunodeficiency virus type 1 reverse transcriptase (RT) gene has been associated with reduced susceptibility to dideoxycytosine (ddC); however, several other mutations at codon 69...
6.
Winters M, Coolley K, Cheng P, Girard Y, Hamdan H, Kovari L, et al.
J Virol
. 2000 Oct;
74(22):10707-13.
PMID: 11044115
Point mutations and inserts in the beta3-beta4 region of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) are associated with resistance to nucleoside analog inhibitors. This report describes HIV-1...
7.
Baxter J, Mayers D, Wentworth D, Neaton J, HOOVER M, Winters M, et al.
AIDS
. 2000 Jul;
14(9):F83-93.
PMID: 10894268
Objective: To determine the short-term effects of using genotypic antiretroviral resistance testing (GART) with expert advice in the management of patients failing on a protease inhibitor and two nucleoside reverse...
8.
Winters M, Baxter J, Mayers D, Wentworth D, HOOVER M, Neaton J, et al.
Antivir Ther
. 2000 Jun;
5(1):57-63.
PMID: 10846594
The frequency of protease and reverse transcriptase (RT) gene mutations was determined in HIV-1 strains from 153 patients entering the CPCRA 046 (GART) study who were failing triple-drug regimens consisting...
9.
Shafer R, Warford A, Winters M, GONZALES M
J Virol Methods
. 2000 Apr;
86(2):143-53.
PMID: 10785289
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated...
10.
Schapiro J, Winters M, Lawrence J, Merigan T
AIDS
. 1999 Apr;
13(3):359-65.
PMID: 10199226
Objectives: To determine the clinical efficacy of the HIV-1 protease inhibitor indinavir (IDV) in saquinavir (SQV)-experienced patients and delineate the developing drug-resistance patterns. Design: Open-label prospective clinical trial. Setting: University...